Tag Archive for: ENDO 2026
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
Admin2026-06-15 07:10:202026-06-15 07:10:20Endocrine Society Annual Meeting (ENDO) 2026
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
Admin2026-06-12 10:39:122026-06-12 10:39:12Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
Admin2026-06-12 09:51:362026-06-14 07:39:55Mortality Among Patients with Prader-Willi Syndrome (MAP-PWS): An Analysis of Healthcare Utilization in the Year Prior to Death Within a Single U.S. Payer
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
Admin2026-06-12 09:41:152026-06-12 09:41:15Long-Term Reductions of Hyperphagia with Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2026/05/Soleno_Medaffairs_Logo.png
Admin2026-06-12 09:38:492026-06-12 09:39:24Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)
